{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:19:09Z","timestamp":1759814349334,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005640","name":"Faculdade de Medicina da Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13027-016-0111-8","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T09:52:15Z","timestamp":1483696335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16\/Ki-67 dual-staining"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5108-924X","authenticated-orcid":false,"given":"R.","family":"Robial","sequence":"first","affiliation":[]},{"given":"A.","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"C. M.","family":"Roteli-Martins","sequence":"additional","affiliation":[]},{"given":"M. F.","family":"Silveira","sequence":"additional","affiliation":[]},{"given":"D.","family":"Stauffert","sequence":"additional","affiliation":[]},{"given":"G. G.","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"I. M.","family":"Linhares","sequence":"additional","affiliation":[]},{"given":"M.","family":"Tacla","sequence":"additional","affiliation":[]},{"given":"M. A.","family":"Zonta","sequence":"additional","affiliation":[]},{"given":"E. C.","family":"Baracat","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"111_CR1","volume-title":"Vigil\u00e2ncia epidemiol\u00f3gica dos agravos de notifica\u00e7\u00e3o compuls\u00f3ria","author":"D Motta","year":"2003","unstructured":"Motta D, Silva AD, Macedo ABRB, et al. Vigil\u00e2ncia epidemiol\u00f3gica dos agravos de notifica\u00e7\u00e3o compuls\u00f3ria. Bras\u00edlia: SES\/DF; 2003."},{"issue":"8","key":"111_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1590\/SO100-720320140005009","volume":"36","author":"LB Fernandes","year":"2014","unstructured":"Fernandes LB, Arruda JT, Approbato MS, et al. Chlamydia trachomatis and Neisseria gonorrhea infection: factors associated with infertility in women treated at a human reproduction public service. Rev Bras Ginecol Obstet. 2014;36(8):353\u20138.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"9","key":"111_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0100-72032012000900007","volume":"34","author":"M Pantoja","year":"2012","unstructured":"Pantoja M, Campos EA, Pitta DR, et al. Prevalence of Chlamydia trachomatis infection among women candidates for in vitro fertilization at a public institution of the State of Sao Paulo, Brazil. Rev Bras Ginecol Obstet. 2012;34(9):425\u201331.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"11","key":"111_CR4","first-page":"328","volume":"33","author":"RC Piazzetta","year":"2011","unstructured":"Piazzetta RC, de Carvalho NS, de Andrade RP, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhea infections in sexual actives young women at a southern Brazilian city. Rev Bras Ginecol Obstet. 2011;33(11):328\u201333.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"111_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-013-3122-3","volume":"289","author":"J Silva","year":"2014","unstructured":"Silva J, Cerqueira F, Medeiros R. Chlamydia trachomatis infection: implications for HPV status and cervical cancer. Arch Gynecol Obstet. 2014;289(4):715\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"111_CR6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","volume":"132","author":"K Nanda","year":"2000","unstructured":"Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytological abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"111_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cncy.21366","volume":"122","author":"J Ordi","year":"2014","unstructured":"Ordi J, Sagasta A, Munmany M, et al. Usefulness of p16\/Ki67 immunostaining in the triage of women referred to colposcopy. Cancer Cytopathol. 2014;122(3):227\u201335.","journal-title":"Cancer Cytopathol"},{"issue":"12","key":"111_CR8","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ijc.28900","volume":"136","author":"C Bergeron","year":"2015","unstructured":"Bergeron C, Ronco G, Reuschenbach M, et al. The clinical impact of using p16 immunochemistry in cervical histopathology and cytology: an update of recent developments. Int J Cancer. 2015;136(12):2741\u201351.","journal-title":"Int J Cancer"},{"key":"111_CR9","doi-asserted-by":"crossref","unstructured":"Bergeron C, von Knebel Doeberitz M. The role of cytology in the 21st century: The integration of cells and molecules. Acta Cytol. 2016;60:540\u2013542.","DOI":"10.1159\/000449402"},{"key":"111_CR10","doi-asserted-by":"crossref","unstructured":"Nayar R, Wilbur DC. The Bethesda system for reporting cervical cytology. definitions, criteria, and explanatory notes. 3rd ed. Springer; 2015.","DOI":"10.1007\/978-3-319-11074-5"},{"issue":"7","key":"111_CR11","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.28173","volume":"133","author":"T Luostarinen","year":"2013","unstructured":"Luostarinen T, Namujju PB, Merikukka M, et al. Order of HPV\/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study. Int J Cancer. 2013;133(7):1756\u20139.","journal-title":"Int J Cancer"},{"issue":"9","key":"111_CR12","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/infdis\/jit346","volume":"208","author":"ML Shew","year":"2013","unstructured":"Shew ML, Ermel AC, Weaver BA, et al. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis. 2013;208(9):1416\u201321.","journal-title":"J Infect Dis"},{"issue":"6","key":"111_CR13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4269\/ajtmh.2012.12-0287","volume":"87","author":"AL Abreu de","year":"2012","unstructured":"de Abreu AL, Nogara PR, Souza RP, et al. Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology. Am J Trop Med Hyg. 2012;87(6):1149\u201351.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"111_CR14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00404-014-3514-z","volume":"291","author":"PA Magalhaes","year":"2015","unstructured":"Magalhaes PA, Miranda CA, Lima EG, et al. Genital tract infection with Chlamydia trachomatis in women attended at a cervical cancer screening program in Northeastern from Brazil. Arch Gynecol Obstet. 2015;291(5):1095\u2013102.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"111_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1590\/S1413-86702003000200001","volume":"7","author":"C Santos","year":"2003","unstructured":"Santos C, Teixeira F, Vicente A, et al. Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus-AM, Brazil, by PCR. Braz J Infect Dis. 2003;7(2):91\u20135.","journal-title":"Braz J Infect Dis"},{"key":"111_CR16","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Available: http:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/gm\/2016\/prt0204_17_02_2016.html"},{"issue":"1","key":"111_CR17","doi-asserted-by":"crossref","first-page":"e0115753","DOI":"10.1371\/journal.pone.0115753","volume":"10","author":"SM Redmond","year":"2015","unstructured":"Redmond SM, Alexander-Kisslig K, Woodhall SC, et al. Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis. PLoS One. 2015;10(1):e0115753.","journal-title":"PLoS One"},{"issue":"4","key":"111_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/eurpub\/ckr046","volume":"22","author":"N Low","year":"2012","unstructured":"Low N, Cassell JA, Spencer B, et al. Chlamydia control activities in Europe: cross-sectional survey. Eur J Public Health. 2012;22(4):556\u201361.","journal-title":"Eur J Public Health"},{"issue":"3","key":"111_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","volume":"40","author":"K Owusu-Edusei Jr","year":"2013","unstructured":"Owusu-Edusei Jr K, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197\u2013201.","journal-title":"Sex Transm Dis"},{"issue":"23","key":"111_CR20","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djq436","volume":"102","author":"M Safaeian","year":"2010","unstructured":"Safaeian M, Quint K, Schiffman M, et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Nat Cancer Inst. 2010;102(23):1794\u2013804.","journal-title":"J Nat Cancer Inst"},{"issue":"3","key":"111_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.20257","volume":"111","author":"JS Smith","year":"2004","unstructured":"Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111(3):431\u20139.","journal-title":"Int J Cancer"},{"issue":"Suppl 5","key":"111_CR22","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"AB Moscicki","year":"2012","unstructured":"Moscicki AB, Schiffman M, Burchell A, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012;30 Suppl 5:F24\u201333.","journal-title":"Vaccine"},{"issue":"7","key":"111_CR23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/sextrans-2013-051431","volume":"90","author":"KE Jensen","year":"2014","unstructured":"Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, Iftner T, Kj\u00e6r SK. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect. 2014;90(7):550\u20135.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"111_CR24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.RCT.0000157092.44680.25","volume":"24","author":"A Longatto Filho","year":"2005","unstructured":"Longatto Filho A, Utagawa ML, Shirata NK, et al. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol. 2005;24(2):118\u201324.","journal-title":"Int J Gynecol Pathol"},{"issue":"15","key":"111_CR25","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","volume":"18","author":"N Wentzensen","year":"2012","unstructured":"Wentzensen N, Schwartz L, Zuna RE, et al. Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154\u201362.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"111_CR26","first-page":"617 e1-7","volume":"199","author":"MI Rosa","year":"2008","unstructured":"Rosa MI, Fachel JM, Rosa DD, et al. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gynecol. 2008;199(6):617 e1-7.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-016-0111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T02:59:44Z","timestamp":1568689184000},"score":1,"resource":{"primary":{"URL":"http:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-016-0111-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1186\/s13027-016-0111-8","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2017,1,6]]},"article-number":"3"}}